Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Nail disorder? 94 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Nail disorder have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.1% of all adverse event reports for CYCLOPHOSPHAMIDE.

94
Reports of Nail disorder with CYCLOPHOSPHAMIDE
0.1%
of all CYCLOPHOSPHAMIDE reports
13
Deaths
15
Hospitalizations

How Dangerous Is Nail disorder From CYCLOPHOSPHAMIDE?

Of the 94 reports, 13 (13.8%) resulted in death, 15 (16.0%) required hospitalization, and 3 (3.2%) were considered life-threatening.

Is Nail disorder Listed in the Official Label?

Yes, Nail disorder is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Nail disorder?

ADALIMUMAB (1,175) METHOTREXATE (1,121) RITUXIMAB (1,017) SECUKINUMAB (980) ETANERCEPT (947) INFLIXIMAB (915) TOCILIZUMAB (906) LEFLUNOMIDE (877) GOLIMUMAB (876) CERTOLIZUMAB PEGOL (842)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Nail disorder Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Nail disorder Reports All Drugs Causing Nail disorder CYCLOPHOSPHAMIDE Demographics